MOUNTAIN VIEW, Calif., Jan. 25 /PRNewswire/ -- Tenaxis Medical has completed enrollment of its pivotal US study for the ArterX Vascular Sealant™. The study was designed to enroll up to 220 patients who were scheduled to receive a synthetic vascular graft or patch at 12 investigational sites wi
http://digg.com/u1LLUf
No comments:
Post a Comment